Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Intellective Bio
company
About
Intellective Bio is a CDMO focusing on biopharmaceutical process development and large-scale production.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥500M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Intellectual Bio specializes in the fields of biopharmaceutical development, commercial production, and Biologics Development. IntellectiveBio is equipped with technical platforms including Protein Science, Cell Engineering, Cell Culture, Protein Purification, Analytical Science, Formulation Development
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥500M
Intellective Bio has raised a total of
¥500M
in funding over 2 rounds. Their latest funding was raised on
Aug 5, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 5, 2022 | Series C | ¥500M | 1 |
Gaorong Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Intellective Bio is funded by 1 investors.
Gaorong Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Gaorong Capital
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
